Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Perry Andrew Create: Alert

All | News | Filings
Date FiledTypeDescription
07/07/2023 4 Perry Andrew (Chief Commercial Officer) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Sold 355 shares @ $2.4537, valued at $871.1
05/12/2023 4 Perry Andrew (Chief Commercial Officer) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Granted 35,000 shares @ $0
01/05/2023 4 Perry Andrew (Chief Commercial Officer) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Granted 16,100 shares @ $0
Sold 820 shares @ $5.5756, valued at $4.6k
Granted 32,100 options to buy @ $5.73, valued at $183.9k
01/05/2022 4 Perry Andrew (Chief Commercial Officer) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Granted 6,000 shares @ $0
Granted 26,500 options to buy @ $10.69, valued at $283.3k
08/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2021 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy